Clinical Trials Directory

Trials / Sponsors / Pharmazz, Inc.

Pharmazz, Inc.

Industry · 13 registered clinical trials — 7 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingMulticentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients With ARDS
Acute Respiratory Distress Syndrome (ARDS)
Phase 22026-05-01
Not Yet RecruitingA Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent
Hypovolemic Shock
Phase 32026-02-01
RecruitingAssess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Acute Ischemic Stroke, Cerebral Stroke
Phase 32025-07-24
RecruitingStudy to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Acute Cerebral Ischemia
Phase 42024-01-08
RecruitingAssess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
Hypoxic-Ischemic Encephalopathy, Neonatal Asphyxia, Neonatal Encephalopathy
Phase 22023-09-06
RecruitingA Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients
Hypovolemic Shock
Phase 42021-08-13
CompletedEfficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke
Cerebral Ischemia, Cerebral Infarction, Stroke, Acute
Phase 32019-11-10
CompletedEfficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic Shock
Hypovolemic Shock
Phase 32019-01-31
RecruitingPMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury
Acute Spinal Cord Injury
Phase 22019-01-10
CompletedPMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease
Alzheimer Disease, Dementia
Phase 22018-03-23
CompletedPMZ-1620 (Sovateltide) in Acute Ischemic Stroke Patients
Acute Stroke, Cerebral Ischemia
Phase 22018-01-19
CompletedPMZ-2010 (Centhaquine) as a Resuscitative Agent for Hypovolemic Shock
Hypovolemic Shock, Blood Loss
Phase 22017-05-29
CompletedA Study to Determine the Safety, Tolerability and Pharmacokinetics of PMZ-2010 (Centhaquin) in Healthy Volunte
Healthy
Phase 12014-10-01